series-a
Stage
3
Investors
About
Pharnext develops drug repositioning therapies for neurodegenerative and rare diseases using its proprietary Pleotherapy platform to identify new therapeutic combinations.
Explore Pharnext's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.